Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study) M Nasser, S Larrieu, S Si-Mohamed, K Ahmad, L Boussel, M Brevet, ... European Respiratory Journal 57 (2), 2021 | 130 | 2021 |
Systematic review with meta‐analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B M Houot, Y Ngo, M Munteanu, S Marque, T Poynard Alimentary pharmacology & therapeutics 43 (1), 16-29, 2016 | 117 | 2016 |
Cardiovascular mortality and calcium and magnesium in drinking water: an ecological study in elderly people S Marque, H Jacqmin-Gadda, JF Dartigues, D Commenges European journal of epidemiology 18, 305-309, 2003 | 99 | 2003 |
Early detection of poor outcome after mild traumatic brain injury: predictive factors using a multidimensional approach a pilot study S Caplain, S Blancho, S Marque, M Montreuil, N Aghakhani Frontiers in neurology 8, 666, 2017 | 42 | 2017 |
A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial S Sadrin, S Sennoune, B Gout, S Marque, J Moreau, K Zinoune, ... Digestive and Liver Disease 52 (5), 534-540, 2020 | 39 | 2020 |
Efficacy of psychoeducation and cognitive rehabilitation after mild traumatic brain injury for preventing post-concussional syndrome in individuals with high risk of poor … S Caplain, G Chenuc, S Blancho, S Marque, N Aghakhani Frontiers in neurology 10, 929, 2019 | 39 | 2019 |
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study) M Nasser, S Larrieu, L Boussel, S Si-Mohamed, F Bazin, S Marque, ... Respiratory Research 22 (1), 162, 2021 | 35 | 2021 |
Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention L Baschet, S Bourguignon, S Marque, I Durand-Zaleski, E Teiger, ... Open Heart 3 (2), e000445, 2016 | 32 | 2016 |
Tibial tubercle torsion, a new factor of patellar instability V Chassaing, JM Zeitoun, M Camara, JL Blin, S Marque, MD Chancelier Orthopaedics & Traumatology: Surgery & Research 103 (8), 1173-1178, 2017 | 31 | 2017 |
MitraClip therapy in mitral regurgitation: a Markov model for the cost-effectiveness of a new therapeutic option P Guerin, S Bourguignon, N Jamet, S Marque Journal of medical economics 19 (7), 696-701, 2016 | 25 | 2016 |
Power and sample size determination in clinical trials with multiple primary continuous correlated endpoints P Lafaye de Micheaux, B Liquet, S Marque, J Riou Journal of biopharmaceutical statistics 24 (2), 378-397, 2014 | 24 | 2014 |
Impact of needle-based confocal laser endomicroscopy on the therapeutic management of single pancreatic cystic lesions M Palazzo, A Sauvanet, R Gincul, I Borbath, G Vanbiervliet, R Bourdariat, ... Surgical endoscopy 34, 2532-2540, 2020 | 15 | 2020 |
Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial S Sadrin, SR Sennoune, B Gout, S Marque, J Moreau, J Grillasca, O Pons, ... Cellular and Molecular Biology 63 (9), 122-131, 2017 | 10 | 2017 |
Bioavailability of stabilised ferrous gluconate with glycine in fresh cheese matrix: a novel iron compound for food fortification F Pizarro, J Boccio, M Salgueiro, M Olivares, E Carmuega, R Weill, ... Biological trace element research 151, 441-445, 2013 | 9 | 2013 |
Epidemiology, mortality and healthcare resource utilization associated with systemic sclerosis-associated interstitial lung disease in France V Cottin, S Larrieu, L Boussel, S Si-Mohamed, F Bazin, S Marque, ... Frontiers in Medicine 8, 699532, 2021 | 7 | 2021 |
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases D Berdaï, F Thomas-Delecourt, K Szwarcensztein, A d’Andon, ... Therapies 73 (1), 13-24, 2018 | 6 | 2018 |
A strict arcsine regression model CC Kokonendjil, S Marquezt Trends in African Diaspora Mathematics Research, 95, 2007 | 6 | 2007 |
Demandes d’études post-inscription (EPI), suivi des patients en vie réelle: Évolution de la place des bases de données D Berdaï, F Thomas-Delecourt, K Szwarcensztein, A d’Andon, ... Therapies 73 (1), 1-12, 2018 | 3 | 2018 |
Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system … M Nasser, S Larrieu, L Boussel, S Si-Mohamed, F Diaz, S Marque, ... European Respiratory Journal 56 (suppl 64), 2020 | 2 | 2020 |
Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France M Nasser, S Larrieu, L Boussel, S Si-Mohamed, F Bazin, S Marque, ... European Respiratory Journal 56 (suppl 64), 2020 | 2 | 2020 |